Pranlukast, a cysteinyl leukotriene receptor antagonist, attenuates allergen-induced early- and late-phase bronchoconstriction and airway hyperresponsiveness in asthmatic subjectsAllan J. Hamilton, Paul M. O’Byrne, Paul Stober et al.|Journal of Allergy and Clinical Immunology|1998Cited by 137